Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” across its content.
    Difference
    1%
    Check dated 2026-10-21T22:36:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T22:39:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T22:49:21.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study content, with a 403 header and a Home link. This indicates access to the study record is blocked.
    Difference
    17%
    Check dated 2026-09-23T22:31:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.7.0, signaling a new revision of the study record.
    Difference
    0.0%
    Check dated 2026-09-16T22:09:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision label v3.6.6 replaces the previous v3.6.5 on the page, indicating a template or backend update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-09-02T20:31:31.000Z thumbnail image

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.